Pleasanton, CA, United States of America

Monica Nagendran

This inventor holds 3 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: 10X Genomics, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Monica Nagendran: Innovator in Biological Analysis

Introduction

Monica Nagendran is a prominent inventor based in Pleasanton, CA (US). She has made significant contributions to the field of biological analysis, holding two patents that showcase her innovative approach to scientific challenges.

Latest Patents

Her latest patents include "Catalytic de-crosslinking of samples for in situ analysis," which relates to methods and compositions for in situ analysis involving catalytic de-crosslinking of biological samples. Another notable patent is "Methods of measuring mislocalization of an analyte," which provides methods for determining the mislocalization of an analyte by capturing it on an array and measuring the mislocalization distance.

Career Highlights

Monica currently works at 10x Genomics, Inc., where she applies her expertise to advance the company's mission in genomic technologies. Her work has been instrumental in developing innovative solutions that enhance the understanding of biological systems.

Collaborations

She collaborates with talented individuals such as Jonathan Cheng and Eswar Prasad Ramachandran Iyer, contributing to a dynamic research environment that fosters innovation.

Conclusion

Monica Nagendran's contributions to the field of biological analysis through her patents and work at 10x Genomics, Inc. highlight her role as a leading inventor in the industry. Her innovative methods continue to push the boundaries of scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…